Therefore, testosterone supplementation, concomitant aromatase inhibitors [182], and AEDs with aromatase-inhibiting properties should be further investigated as a beneficial treatment for male patients with epilepsy [161, 162, 163, 177, 178, 185, 186, 187]. This evidence concerns the gene CYP19A1 and epilepsy.